Insight Molecular Diagnostics Inc (IMDX) Stock Price, Quote & News

Company Profile

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The compa...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 949 409 7600

Website: www.imdxinc.com

Address:

2 International Plaza Dr., Suite 510, Nashville, United States

JohnPDaly Aug. 17 at 4:39 PM

$IMDX better cheaper faster.

0 · Reply

Logic102 Aug. 17 at 4:11 PM

$IMDX I was pleased with the event. An actual cardiologist using the product and other versions of similar products gave pragmatic answers about Graft Assure having definite advantages for patients and physicians.

0 · Reply

Logic102 Aug. 17 at 2:52 PM

$IMDX Event starts in 7 minutes, should give more color.

0 · Reply

topstockalerts Aug. 15 at 12:01 AM

$IMDX the move looks more deliberate than random.

0 · Reply

Logic102 Aug. 14 at 2:44 PM

$IMDX Back in near the close and in the after hours yesterday. This may be a somewhat risky stock, but I really like the Risk/Reward formula. The upside is huge at this tiny M Cap.

1 · Reply

JohnPDaly Aug. 14 at 1:57 PM

$IMDX fuckery.

0 · Reply

RUNNINWILD Aug. 14 at 1:43 PM

$IMDX these foolish games

0 · Reply

TI7812 Aug. 13 at 11:59 PM

$BCRX $IMDX anyone find a reason for the selling? I have not. just two of many biotechs I follow

2 · Reply

Wisenheimer Aug. 13 at 9:24 PM

$IMDX we will see another capital raise $3 or lower

0 · Reply

JohnPDaly Aug. 13 at 8:30 PM

$IMDX bought more.

0 · Reply

Insight Molecular Diagnostics Transcript: KOL event

Aug 11, 2026, 4:05 PM EDT - 7 days ago

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Insight Molecular Diagnostics Shareholder letter: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Insight Molecular Diagnostics Earnings release: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Insight Molecular Diagnostics Quarterly report: Q2 2026

2026-08-10T20:46:18.000Z - 8 days ago

Insight Molecular Diagnostics reports Q2 EPS (31c), consensus (23c)

Aug 4, 2026, 7:00 AM EDT - 15 days ago

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

2026-07-23T13:30:33.000Z - 27 days ago

Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay

Jul 23, 2026, 8:00 AM EDT - 27 days ago

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Jul 16, 2026, 3:22 PM EDT - 4 weeks ago

Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio

Jun 29, 2026, 8:00 AM EDT - 7 weeks ago

IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper

Jun 22, 2026, 2:07 PM EDT - 2 months ago

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

Jun 16, 2026, 4:05 PM EDT - 2 months ago

Favorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistry

Jun 11, 2026, 4:17 PM EDT - 2 months ago

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Jun 9, 2026, 4:05 PM EDT - 2 months ago

iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress

May 13, 2026, 5:00 PM EDT - 3 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Insight Molecular Diagnostics Earnings release: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Insight Molecular Diagnostics Shareholder letter: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Insight Molecular Diagnostics Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 3 months ago

IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization

May 13, 2026, 4:00 PM EDT - 3 months ago

Insight Molecular Diagnostics Slides: Investor presentation

May 6, 2026, 4:05 PM EDT - 3 months ago

iMDx to Release First Quarter 2026 Results on May 13, 2026

Apr 30, 2026, 8:00 AM EDT - 3 months ago

Insight Molecular Diagnostics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

Insight Molecular Diagnostics Proxy statement: Proxy filing

Apr 15, 2026, 9:30 AM EDT - 4 months ago

Insight Molecular Diagnostics Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 8:00 AM EDT - 4 months ago

Real-World Evidence and Industry Momentum Builds for iMDx's Flagship GraftAssure Assay

Mar 26, 2026, 5:00 PM EDT - 5 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 5 months ago

Insight Molecular Diagnostics Shareholder letter: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 5 months ago

Insight Molecular Diagnostics Annual report: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 5 months ago

Insight Molecular Diagnostics Earnings release: Q4 2025

2026-03-26T20:51:47.000Z - 5 months ago

Insight Molecular Diagnostics submits GraftAssureDx for FDA review

2026-03-26T20:45:14.000Z - 5 months ago

Insight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year

Mar 26, 2026, 4:05 PM EDT - 5 months ago

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Mar 26, 2026, 4:00 PM EDT - 5 months ago

Insight Molecular Diagnostics Slides: Investor presentation

Mar 20, 2026, 8:00 AM EDT - 5 months ago

iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

2026-03-13T12:13:12.000Z - 5 months ago

Insight Molecular Diagnostics highlights publication of study on GraftAssure

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score

2026-03-03T13:21:06.000Z - 6 months ago

Insight Molecular Diagnostics completes milestones advancing GraftAssureDx

Mar 3, 2026, 8:00 AM EST - 6 months ago

Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission

2026-02-17T13:50:59.000Z - 6 months ago

Insight Molecular Diagnostics price target raised to $12 from $8 at Lake Street

2026-02-11T13:23:15.000Z - 6 months ago

Insight Molecular Diagnostics prices 4.53M shares at $5.75 in direct offering

Feb 11, 2026, 8:00 AM EST - 6 months ago

iMDx Announces $26.0 Million Registered Direct Offering

2026-01-13T14:13:54.000Z - 7 months ago

Insight ‘congratulated’ STAR working group on organ health testing paper

Jan 13, 2026, 9:00 AM EST - 7 months ago

IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring

Jan 7, 2026, 4:05 PM EST - 7 months ago

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation

2026-01-06T13:05:54.000Z - 8 months ago

Insight Molecular Diagnostics appoints Nick Ioannou as VP, medical affairs

Jan 6, 2026, 8:00 AM EST - 8 months ago

iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch

2026-01-05T12:11:39.000Z - 8 months ago

iMDx prepares for U.S. commercial launch of GraftAssureDx

Jan 5, 2026, 7:00 AM EST - 8 months ago

iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion

2025-11-10T22:10:29.000Z - 10 months ago

Insight Molecular Diagnostics reports Q3 EPS (34c) vs. (98c) last year

Nov 10, 2025, 5:00 PM EST - 10 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025

Nov 10, 2025, 5:00 PM EST - 10 months ago

Insight Molecular Diagnostics Shareholder letter: Q3 2025

Nov 10, 2025, 5:00 PM EST - 10 months ago

Insight Molecular Diagnostics Quarterly report: Q3 2025

Nov 10, 2025, 5:00 PM EST - 10 months ago

Insight Molecular Diagnostics Earnings release: Q3 2025

Nov 10, 2025, 4:05 PM EST - 10 months ago

IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch

Nov 3, 2025, 4:05 PM EST - 10 months ago

iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week

Oct 13, 2025, 4:05 PM EDT - 11 months ago

iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch

2025-10-06T11:35:23.000Z - 11 months ago

Insight Molecular says kidney transplant patient achieved ‘immune reset’

Oct 6, 2025, 7:15 AM EDT - 11 months ago

iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset' with Novel Therapy and GraftAssure Monitoring

2025-09-24T11:15:23.000Z - 11 months ago

Insight Molecular Diagnostics announces attendance at two industry conferences

Sep 24, 2025, 7:05 AM EDT - 11 months ago

Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando

Sep 16, 2025, 7:00 AM EDT - 1 year ago

Insight Molecular Diagnostics Slides: Investor presentation

Sep 8, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

2025-09-08T11:25:06.000Z - 1 year ago

Insight Molecular Diagnostics announces novel registry database

Sep 8, 2025, 7:15 AM EDT - 1 year ago

Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database

2025-09-08T11:10:23.000Z - 1 year ago

Insight Molecular Diagnostics enrolls first patient in GraftAssureDx trial

Sep 8, 2025, 7:00 AM EDT - 1 year ago

IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants

Aug 26, 2025, 4:05 PM EDT - 1 year ago

iMDx to Participate in NYC Investment Conferences September 8 - 11

Aug 15, 2025, 4:00 PM EDT - 1 year ago